Reducing nausea and vomiting after bariatric surgery
Decreasing Post-Operative Nausea and Vomiting in the Bariatric Surgical Patient
NA · Methodist Health System · NCT06110416
This study is testing a nausea relief inhaler to see if it can help people feel better after bariatric surgery by reducing nausea and vomiting.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 50 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | Methodist Health System (other) |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Mansfield, Texas) |
| Trial ID | NCT06110416 on ClinicalTrials.gov |
What this trial studies
This study investigates the effectiveness of a nausea relief inhaler in reducing post-operative nausea and vomiting in patients undergoing bariatric surgery. Given that a significant percentage of these patients experience nausea and vomiting, the study aims to evaluate whether aromatherapy and essential oils can provide relief without the side effects associated with traditional medications. The research will involve patients aged 18 to 65 who meet specific eligibility criteria and will assess the inhaler's impact on patient satisfaction and mobility post-surgery.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 to 65 who are scheduled for bariatric surgery and can attend a pre-operative class.
Not a fit: Patients with a BMI greater than 60, those on pre-operative nausea medication, or individuals with specific allergies or respiratory conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly enhance patient comfort and recovery after bariatric surgery.
How similar studies have performed: While the use of nausea relief inhalers has been studied in other surgical populations, this specific application in bariatric patients is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18 to 65 years old * Attend the pre-operative class * Must be able to read English * Admitted to B4 surgical acute unit * Surgery after May 31st, 2020 Exclusion Criteria: * BMI greater than 60 * Pre-operatively on nausea medication * Allergy to spearmint, lemon, ginger, and/or cedarwood * History of Asthma or chronic obstructive pulmonary disease(COPD) * Patient intubated or sedated for the 24 hours after surgery
Where this trial is running
Mansfield, Texas
- Methodist Mansfield Medical Center — Mansfield, Texas, United States (RECRUITING)
Study contacts
- Principal investigator: Ashley Attaway, RN — Methodist Mansfield Medical Center
- Study coordinator: Colette Ngo Ndjom, MS
- Email: ClinicalResearch@mhd.com
- Phone: 214-947-1280
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Nausea, Postoperative, Vomiting, Postoperative